Liminal BioSciences Inc. (LMNL) Stock Analysis
DELISTED 2023
What happened to Liminal BioSciences Inc. (LMNL) stock?
Liminal BioSciences Inc. (LMNL) no longer trades on public markets. It was delisted in September 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- September 2023
- Last recorded price (historical):
- $8.50 (last quote on record before the September 2023 delisting; historical, not a current quote)
Market cap $27.6M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Liminal BioSciences Inc. (LMNL). Liminal BioSciences Inc. is a clinical-stage biopharmaceutical company developing novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases.
Last analyzed: Jun 15, 2026Liminal BioSciences Inc. (LMNL) Healthcare & Pipeline Overview
More about this archive record
Can I still buy LMNL shares?
No. LMNL stopped trading on public markets in September 2023, so the shares are not available through a broker. Anything you see quoted for LMNL elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before LMNL stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Liminal BioSciences Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.